Discontinued in Canada following regulatory recommendations in the United States and the European Union to not approve Zeftera ( due to concerns regarding the conduct of clinical trials). Further information can be obtained from the Health Canada Advisories, Warning and Recalls website (http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2010/index-eng.php).